Evelyn Warner, Author at Labiotech.eu

News and Trends 7 Feb 2018

Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster

TC Biopharm has signed a new pharma partner, the Japan-based NIPRO Corporation, who will give the biotech a leg up in the CAR-T game. Hot on the heels of the…

February 7, 2018 - 1 minutemin - By Evelyn Warner

Interview 7 Feb 2018

Hookipa CEO “Sleeps Quite Well at Night” with €50M Cash Pile and Cancer Vaccine Progress

Did you miss us in Vienna? Here's the first of our two interviews from the Refresh meetup last month: Jörn Aldag, CEO of Hookipa, talked to us about the importance…

February 7, 2018 - 4 minutesmins - By Evelyn Warner

More News! 6 Feb 2018

Biotech Barometer: How is biotech doing on the European markets?

How did biotech finish last year on Euronext? The exchange has released its report for H2 of 2017 for the 49 biotechs listed on the markets, including giants Galapagos and…

February 6, 2018 - 3 minutesmins - By Evelyn Warner

lig biowise diagnostics antimicrobial resistance

More News! 5 Feb 2018

A DNA-Based Diagnostic Company Rakes in £1.8M to Combat Antimicrobial Resistance

A new molecular diagnostics company, LIG Biowise, has just closed a £1.8M Series A fundraising round in its effort to combat antimicrobial resistance. Based in Manchester, LIG Biowise, is working on…

February 5, 2018 - 1 minutemin - By Evelyn Warner

Interview 29 Jan 2018

Meet the CEO of the Other Big Biotech Acquisition Target in 2017

Christian Schetter’s company, Rigontec, was acquired by MSD last year for nearly half a billion euro. How did he and the company do it, with only one early-stage candidate? There…

January 29, 2018 - 9 minutesmins - By Evelyn Warner

News and Trends 26 Jan 2018

New British Spinout May Get Snapped Up by Allergan for $400M

KaNDy Therapeutics, a women's health spinout helmed by Mary Kerr, is rumored to be in acquisition talks that value the company at $400M (€322M). Details are sparse, but according to a…

January 26, 2018 - 1 minutemin - By Evelyn Warner

News and Trends 25 Jan 2018

Novartis Will Bring US Gene Therapy for Blindness to Europe

The Swiss pharma has bought into the gene editing therapy game in a deal with Spark worth $170M (€137M) for commercialization rights outside the US. Novartis first marked out its…

January 25, 2018 - 2 minutesmins - By Evelyn Warner

News and Trends 23 Jan 2018

Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad

Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire Juno: Cellectis rides the wave but Celyad misses it. Shortly after the mega-acquisition of Kite by…

January 23, 2018 - 2 minutesmins - By Evelyn Warner

Interview 22 Jan 2018

Bravo! An Interview with the CEO of Takeda’s Recent Cell Therapy Target

I sat down with Eduardo Bravo, CEO of TiGenix, to talk about the technology that made his company so attractive to the pharma giant. After beginning his career in big…

January 22, 2018 - 6 minutesmins - By Evelyn Warner

News and Trends 18 Jan 2018

Report from JP Morgan 2018: Taking the Financial Temperature of Biotech

As heard at JP Morgan 2018, last year was an ok year for biotech. But how does 2018 look? Here are the thoughts of a panel convened to discuss the…

January 18, 2018 - 5 minutesmins - By Evelyn Warner

Best in Biotech 9 Jan 2018

Happy 2018, Here Are the Top 9 European Biotech Companies To Watch

As the 2017 reports roll in, we're already turning our gaze to 2018. These are the top European biotech companies to watch in the new year. The results from last…

January 9, 2018 - 5 minutesmins - By Evelyn Warner

alzheimers disease acimmune andrea pfeifer 1

Interview 8 Jan 2018

Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease

Efforts to treat Alzheimer’s Disease have been hit with failure after failure in the last year or so. Andrea Pfeifer, co-founder and CEO of AC Immune, told me about how…

January 8, 2018 - 8 minutesmins - By Evelyn Warner

Best in Biotech 28 Dec 2017

Bored Between the Holidays? Watch these Biotech Videos!

Christmas might have passed, but we have more videos for you to watch on a dreary winter day! Here are our highlights from 2017. It's vacation time! If you've worn…

December 28, 2017 - 4 minutesmins - By Evelyn Warner

Best in Biotech 27 Dec 2017

The Biggest Biotech News of 2017: What Happened This Year?

Still catching up on news? We've picked out the most exciting things that happened besides clinical results and finance. Here's the biggest biotech news of 2017. We've been recapping the…

December 27, 2017 - 3 minutesmins - By Evelyn Warner

Best in Biotech 26 Dec 2017

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

We love hearing from our readers, and we listen to what they like! Here are the long reads from our best biotech articles of 2017. We gave you a list…

December 26, 2017 - 6 minutesmins - By Evelyn Warner

More News! 21 Dec 2017

Oxford Biotech Makes a Latin American Deal for Its Antibiotic

In a deal worth up to €23.6M, Summit Therapeutics licensed the commercialization of its new antibiotic ridinilazole to Eurofarma. Oxford-based Summit Therapeutics is working on new antibiotics to fight antimicrobial…

December 21, 2017 - 1 minutemin - By Evelyn Warner

Best in Biotech 19 Dec 2017

Labiotech’s Favorite Biotechs: Which companies do we like and why?

We've already named the best companies of the year, but which are our favorite companies? Here's who they are and why! We tried to be objective when we went through the…

December 19, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 12 Dec 2017

The Largest Medtech Fund in Europe is Here Thanks to This Dutch VC

LSP has closed a €280M fund, Health Economics Fund 2, that is dedicated to medtech with a focus on containing costs while delivering effective healthcare. There's a new medtech fund…

December 12, 2017 - 2 minutesmins - By Evelyn Warner

More News! 5 Dec 2017

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

ChemomAb kicked off its antibody efforts as a company in 2011, and its $10M Series B has attracted none other than Peter Thiel. Israeli biotech has been attracting quite sizeable…

December 5, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 5 Dec 2017

The Philippines Blocks Sanofi’s Dengue Vaccine for Safety Reasons

Following alarming research about the safety of Sanofi's dengue vaccine, Dengvaxia, The Philippines has halted its sale, distribution and marketing "to protect the general public." Before Sanofi Pasteur distributed its…

December 5, 2017 - 3 minutesmins - By Evelyn Warner

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

About

Articles by Evelyn Warner

Outsourcing in life science R&D today

Are you out-licensing?

Subscribe to our newsletter to get the latest biotech news!